Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
fludeoxyglucose F 18
United Therapeutics Europe Ltd
Testicular Germ Cell Tumor
1 trial -
fludeoxyglucose F 18
United Therapeutics Europe Ltd
Lung Cancer
1 trial -
formoterol
Teva Pharma GmbH
Asthma
1 trial -
foundational treatment
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
fructose
Ultragenyx UK Limited
Sickle Cell Anemia
1 trial -
goserelin acetate
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
growth hormone
Ultragenyx UK Limited
Werner's Syndrome
1 trial -
high protein
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Life Quality
1 trial -
insulin aspart
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type 2 Diabetes Mellitus
1 trial -
insulin injection 15 minutes before meals
The First People's Hospital of Lianyungang
Diabetes
1 trial -
irinotecan hydrochloride liposome injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Biliary Tract Carcinoma
1 trial -
leuprorelin
The First People's Hospital of Lianyungang
Hematopoietic Stem Cell Transplantation
1 trial -
live combined Bifidobacteriun, Lactobacillus and Enterococcus capsules
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
low-dose stem cell gel group
The First People's Hospital of Lianyungang
Burn Injury
1 trial -
megestrol
Ultragenyx UK Limited
Acquired Immunodeficiency Syndrome
1 trial -
metformin, topiramate
Hospital Authority, Hong Kong
Obesity
1 trial -
methotrexate
Universal Integrated
Rheumatoid Arthritis
1 trial -
midodrine
Ultragenyx UK Limited
Syncope
1 trial -
modified BEAM
The First People's Hospital of Lianyungang
Autologous Stem Cell Transplantation
1 trial -
modified Ma Xing Shi Gan Decoction
Universal Integrated
Chronic Obstructive Pulmonary Disease
1 trial -
morphine sulfate
Indivior Pty Ltd
Analgesic Response
1 trial -
multi-factorial intervention
United Therapeutics Europe Ltd
Type 2 Diabetes Mellitus
1 trial -
multi-intervention program and protein foods supplementation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sarcopenia
1 trial -
multi-vitamin carbohydrate
The First People's Hospital of Lianyungang
Nausea and Vomiting, Aspiration, Intraoperative
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources